chrisvoncsefalvay/vaers-outcomes huggingface dataset:
We started to notice that after lunch she vomited out her entire lunch while driving over to a friends house. After that, she seemed fine and played in the pool for a bit and everything was normal she did sleep over an hour and a half and seemed a little more tired than usual. After getting home later that evening we noticed that she began to run a small fever. We did not give her anything for the symptoms and she seemed to be fine and slept the entire night through. We then took her to the pediatrician the next day she still had a fever of 100, and at the visit they measured a temperature at 101. COVID-19 test was done and came back negative, they said she was well hydrated, everything else looked great. After getting home she took a two hour nap. Tylenol was given in the middle of the afternoon and fever went down and she seemed completely fine. As of the 12th, she has been completely fine and non symptomatic.
The second dose, that evening was filling unwell and blood sugar rose , next day arm is sore , fitage, blood sugar was high missed work,  day three  blood sugar still high and went to hospital on day four, became dehydrated, ketones and blood sugar was high. Checking
This spontaneous report as received from a nurse via a company representative and refers to a male patient of unknown age. No information about the patient's pertinent medical history, concomitant medications and drug reactions or allergies was reported. On an unknown date, the patient was vaccinated with ZOSTAVAX injection (dose, route of administration, vaccination site, lot # and expiry date were not specified) for prophylaxis. Concomitant therapies included sterile diluent (MERCK STERILE DILUENT). On an unknown date, after receiving ZOSTAVAX, the patient developed shingles. The outcome of the event was unknown. The reporter did not provide the causality assessment between the events and ZOSTAVAX.
Have had a persistent headache and a stiff neck since about 10 hours after Covid vaccination. Today, is day 6. Just read a research paper indicating that stiff neck can be subacute thyroiditis caused by Covid vaccine.
Thursday evening I had chills. Friday morning I woke up with a rash, mostly on the left side of my neck near shoulder. As the day went the rash got worse. Some spots looked like welts.  It spread around my neck and shoulder area heavily. My torso has a slight rash.  I have been taking Allergy Relief to help with the itching. It is now Saturday morning and the rash does seem to be clearing up.
got really sick; red dot on left arm; shakes; sweating; injection site itchy; injection site is the size of a baseball,injection site is growing; injection site painful; shaking; fever; muscle aches; exhaustion; headache; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (got really sick), MACULE (red dot on left arm), TREMOR (shakes), HYPERHIDROSIS (sweating) and VACCINATION SITE PRURITUS (injection site itchy) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037K20A and 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was provided.  Concomitant products included FINASTERIDE (PROPECIA), CITALOPRAM and PROPRANOLOL for an unknown indication.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Jan-2021, the patient experienced ILLNESS (got really sick), MACULE (red dot on left arm), TREMOR (shakes), HYPERHIDROSIS (sweating), VACCINATION SITE PRURITUS (injection site itchy), VACCINATION SITE SWELLING (injection site is the size of a baseball,injection site is growing), VACCINATION SITE PAIN (injection site painful), TREMOR (shaking), PYREXIA (fever), MYALGIA (muscle aches), FATIGUE (exhaustion) and HEADACHE (headache). At the time of the report, ILLNESS (got really sick), MACULE (red dot on left arm), TREMOR (shakes), HYPERHIDROSIS (sweating), VACCINATION SITE PRURITUS (injection site itchy), VACCINATION SITE SWELLING (injection site is the size of a baseball,injection site is growing), VACCINATION SITE PAIN (injection site painful), TREMOR (shaking), PYREXIA (fever), MYALGIA (muscle aches), FATIGUE (exhaustion) and HEADACHE (headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment drug details was provided.   This case was linked to MOD-2021-245590 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 02-Jul-2021: The follow-up document added on 02-jun-2021. Two new events were added, concomitants were added and Batch no for 2nd dose was also added.
Racing heart or fluttering about 45 minutes after injection and also after walking outdoors about 3 blocks with near 0 degree temperature. The fluttering occurred 2 times, interval of about 10 minutes in between each occurrence, lasting around 1 minute or less each occurrence.
60 - 72 hours post vax, the child had 2-3 inch of swelling in legs (toward knee) heat, a little redness. MD felt his could be do to child's Hib vaccine and advised Mom to seek treatment at an ER.
Information has been received from a nurse practitioner concerning a 13 year old female patient who on 15-JAN-2009 was vaccinated intramuscularly with the second dose of GARDASIL vaccine into the upper deltoid. Concomitant therapy included INFLUENZA VIRUS vaccine (unspecified) in the opposite arm. Within a few moments of receiving the second dose of GARDASIL vaccine, the patient fainted. The patient sought unspecified medical attention. Subsequently, the patient recovered. Additional information has been requested.
SWEATING; STOMACH ACHE; STING ON THE RIGHT SIDE OF FACE; NAUSEA PREVENTED FROM EATING ANYTHING; NAUSEA; This spontaneous report received from a patient concerned a 64 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included aches every day due to history of arthritis.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1821287, expiry: UNKNOWN) dose was not reported, administered on 30-JUN-2021 for prophylactic vaccination. No concomitant medications were reported. On 01-JUL-2021, the subject experienced sweating. On 01-JUL-2021, the subject experienced stomach ache. On 01-JUL-2021, the subject experienced sting on the right side of face. On 01-JUL-2021, the subject experienced nausea prevented from eating anything. On 01-JUL-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sting on the right side of face on 01-JUL-2021, was recovering from sweating, nausea, and stomach ache, and the outcome of nausea prevented from eating anything was not reported. This report was non-serious.
Employee received FLUMIST on 10/07/11 about 11:00 am; bilaterally intranasal; employee noted next day about 11:00 am tickle in back of throat which has progressed to a daily cough episode. Over past month sometimes cough precipitates gag reflex.
Information has been received from a nurse practitioner concerning a 12 month old white female with no medical history and no allergies who on 1/20/03 was vaccinated SC in the left leg with a first dose of varicella virus vaccine live (lot # 643530/0599M). On 1/20/03 the patient was also vaccinated IM in the right leg with a third dose of Streptococcus pneumoniae vaccine (lot 488204). There was no illness at the time of vaccination. On 2/3/03 the patient developed a mild case of chicken pox. Subsequently, the patient recovered. No further information is expected.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 01Mar2021 as dose 1, single (Batch/Lot number: unknown), in left arm, on 15Apr2021 as dose 2, single (Batch/Lot number: unknown), in left arm and on 29Dec2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 59 years, in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Tetracycline, reaction(s): "Known Allergies: Tetracycline". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: The patient received anti-viral Paxlovid for the treatment of Covid-19 which started on 03Apr2023 and stopped on 07Apr2023.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Rash all over body 10 days after SPV. Symptoms: RASH&OTH NONSPEC SKIN ERUPTION(R21), PRURITUS, UNSPECIFIED(L299).
Checked with pt on 10-6-07 in AM, her husband reported she was doing fine, 10-8-07 at 9:00 AM she called pharmacy and reported having swelling at injection site that started 10-6-07 in the evening. Told her to take APAP, diphenhydramine and I would check back on her later on 10-8-07.
itchy; swelling; Redness; Tenderness; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness), TENDERNESS (Tenderness), PRURITUS (itchy) and SWELLING (swelling) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Dec-2020, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Dec-2020, the patient experienced ERYTHEMA (Redness) and TENDERNESS (Tenderness). On 06-Jan-2021, the patient experienced PRURITUS (itchy) and SWELLING (swelling). At the time of the report, ERYTHEMA (Redness), TENDERNESS (Tenderness), PRURITUS (itchy) and SWELLING (swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications was reported. Treatment information was not provided.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MODERNATX, INC.-MOD-2021-002594 (E2B Linked Report). This case was linked to MOD-2021-003744, MOD-2021-002594, MOD-2021-002925 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. MODERNATX, INC.-MOD-2021-002594:
Swollen lips and throat and face.  Cold sore on lip.  Trouble breathing. Uvula swollen. Hep A, IPV, Tdap & MCV4 given yesterday.
Booster dose. Vaccine administered on. Vial expired 10/11/21. Vial was removed from freezer to fridge on 10/30/2021 for administration on 11/1/2021.
Left arm pain, "fever off and on especially at night" per pt. Headache, left deltoid swollen, red, tender. Tx: Imitrex, Keflex 500 mg po TID, Tylenol #3, warm compresses.
190 patients (9 different lot numbers) received a vaccine past the beyond; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond).    This case included information of patient 188th out of 190 reported patients.  No concomitant medications were reported. No treatment medications were reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-704335 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704335:Master case
I tested positive months after being fully vaccinated; This spontaneous case was reported by a non-health professional and describes the occurrence of COVID-19 (I tested positive months after being fully vaccinated) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (I tested positive months after being fully vaccinated). At the time of the report, COVID-19 (I tested positive months after being fully vaccinated) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: unknown (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The concomitant medication was not provided by the reporter. Treatment was not provided by the reporter.
Pain down arm to fingers, shoulder pain, neck pain, underarm pain.  Swollen upper arm. Warm to the touch. Low grade fever, weak and very tired. A few red spots appeared on front of neck that itch. Pain so bad at night, couldn't find a position to sleep without pain.
Arm lil sore; Initial information received on 15-Oct-2020 regarding an unsolicited valid non-serious case from a consumer via media .  This case involves patient of unknown demography who experienced arm lil sore (pain in extremity), after receiving INFLUENZA VACCINE.  The patient had no medical history, concomitant disease or risk factor.  Past medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient developed a non-serious arm lil sore (pain in extremity) (unknown latency) following the administration of INFLUENZA VACCINE.  No laboratory data reported.  It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome was not reported for the event pain in extremity.  There will be no information on the batch number for this case.
Moderna Covid-19 Vaccine EUA, I experienced headache, nausea, vomiting, diarrhea, fever, chills and aches for several hours. My fever went down around 6AM and was back to normal by 7AM. I am still experiencing headache and aches.
The left deltoid had increased warmth, increased pain, increased swelling post the TD vax on 3/8/01.
SWELLING OF EYEBROWS; CHILLS; FEVER; FATIGUE; NAUSEA; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included blood disorder called mus.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced swelling of eyebrows, chills, fever, fatigue, and nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the swelling of eyebrows, fever, chills, fatigue and nausea was not reported. This report was non-serious.
15 yr 6 mo twin female patient with SMA type 2, associated chronic respiratory failure, neuromuscular scoliosis, restrictive lung mechanics and ineffective airway clearance, disability requiring wheelchair for ambulation, spasticity and acquired right equinovarus--who noticed a left-sided firm breast lump incidentally discovered 1 week prior to presentation to clinic on 3/15/2022; noticed significant tenderness after receiving COVID vaccine booster dose (#3) on 3/10/2022
Vomiting; Had 103 Fever; Headache; Nausea; Body aches; This is a spontaneous report from a contactable consumer (Patient's parent). A 15-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot number: EW0179; expiration date: 31Aug2021) via an unspecified route of administration in right arm on 12Jun2021 (at the age of 15-year-old) for COVID-19 immunization. Patient had no medical history and concomitant medications. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot number: EW0183) in unspecified route of administration in left arm on 22May2021 (at the age of 15-year-old) for COVID-19 immunization and had no reaction. On 13Jun2021, one day after vaccination, the patient had 103 fever, headache, nausea, body aches and on 14Jun2021, two days after vaccination, the patient experienced vomiting. As per the reporter, patient was getting the side effect for 5 days now. She had 103 fever for day and half. She was experiencing severe headache. Now, she was experiencing headache, nausea, vomiting and body aches. Reportedly, It was started when she had the second vaccination, started on Sunday and Monday she had a fever and had experience headache and body aches and then on Tuesday fever went away and she started experiencing headache, nausea and vomiting still going on. Reporter's daughter received the vaccine shot, the second one, last Saturday, she was still experiencing side effects. She was having nausea, headache, body ache, and she had 103 fever for three days. Reporter mentioned that they were trying to find out what treatment should they give her. Outcome of the event 103 fever was resolved on 16Jun2021 and for the event headache, nausea, pain and vomiting were not resolved.  No follow-up attempts are needed. No further information is expected.
Weakness in legs; Joint pain in finger; Dizziness/weakness; Dizziness/weakness; Headache; Bad chills; Tiredness; Nausea; Feeling unwell; Injection site pain/swelling/redness; Injection site pain/swelling/redness; Injection site pain/swelling/redness; Muscle pain; Swollen lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0191) via an unspecified route of administration in the left arm on 02Aug2021 at 11:00 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history included antinuclear factor abnormal (ANA levels) and allergy to sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0191), via an unspecified route of administration in the left arm on 07Jul2021 at 11:00 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 02Aug2021 at 11:00, the patient experienced weakness in legs, joint pain in fingers, dizziness/weakness, headache, bad chills, tiredness, nausea, feeling unwell, injection site pain/ swelling/ redness, muscle pain and swollen lymph nodes. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events weakness in legs, joint pain in finger, dizziness/weakness, headache, bad chills, tiredness, nausea, feeling unwell, injection site pain/ swelling/ redness, muscle pain and swollen lymph nodes was not recovered at the time of this report.
Very large area of bruising which went away eventually, but pt still has soreness in the arm as of 12/7/11.
arm soreness; some fatigue; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71-year-old male patient received BNT162b2 (BNT162B2), on 25Oct2021 at 10:00 as dose 3 (booster), single (Lot number: FF8839) at the age of 70 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing); "borderline high cholesterol" (unspecified if ongoing); "BPH" (unspecified if ongoing). Concomitant medication(s) included: HYDROCHLOROTHIAZIDE, start date: Jun2001; OLMESARTAN MEDOXOMIL, start date: Oct2017; ROSUVASTATIN, start date: Jun2018. Past drug history included: Amoxicillin, reaction(s): "Known allergies: amoxicillin". Vaccination history included: BNT162b2 (vaccine brand=Pfizer/BioNTech, vaccine brand unknown=False, vaccine administration date=04Mar2021, vaccine administration time=10:00 AM, vaccine lot number=EL9267, vaccine lot unknown=False, vaccine dose number=2, vaccine dose number unknown=False, vaccine location=Right arm), administration date: 04Mar2021, when the patient was 69-year-old, for Covid-19 Immunization, reaction(s): "arm soreness", "some fatigue"; BNT162b2 (vaccine brand=Pfizer/BioNTech, vaccine brand unknown=False, vaccine administration date=11Feb2021, vaccine administration time=10:00 AM, vaccine lot number=EL9261, vaccine lot unknown=False, vaccine dose number=1, vaccine dose number unknown=False, vaccine location=Right arm), administration date: 11Feb2021, when the patient was 69-year-old, for Covid-19 Immunization, reaction(s): "arm soreness", "some fatigue". The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "arm soreness"; FATIGUE (non-serious), outcome "unknown", described as "some fatigue". Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible. No further information is expected.
Patient reports intermittent tingling in (R) arm since the evening of vaccination. Refer to Neurology.
Initial report received on 05 November 2013 from a pharmacist. An 90 year old female patient, medical history and concomitant medications were not reported, received a dose of FLUZONE HD (lot # unknown) at unknown site on an unspecified date. It was reported that a patient had muscle ache and pain. Event outcome was unknown at the time of report. List of documents held by sender: none